06 February 2026
06 February 2026
Eyas Medical Imaging is currently scaling up operations with plans to commercialise the system in the US later this year.
The Phase IIa clinical trial is scheduled to begin in the first half of 2026.
Apotex’s Searchlight Pharma will seek marketing authorisation and manage commercialisation activities for Nebido in Canada.
With this FDA approval, Hologic now offers three guideline-recommended methods: Pap testing, HPV primary testing, and co-testing.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
